Vnitr Lek 2005, 51(5):533-538

Portal vein flow is associated to central hemodynamics and biochemical signs of liver lesion in chronic congestive heart failure

E. Goncalvesová*, P. Lesný, P. Chňupa, M. Luknár, J. Fabián
Transplantačné oddelenie Slovenského ústavu srdcových a cievnych chorôb, Bratislava, Slovenská republika, primár prof. MUDr. Juraj Fabián, DrSc.

Chronic congestive heart failure (CHF) is a syndrome with multiorgan manifestation. During chronic congestive HF changes in portal vein (PV) flow develop. Instead of normal continuous, pulsatile flow with higher diastolic velocity appears. Aim of the study was to describe PV flow characteristics in advanced CHF and compared them with parameters of central hemodynamics and biochemical sings of liver lesion.

Patients and methods:
74 pts (60 males) aged 47.2 ± 20.2 year with severe left ventricular systolic dysfunction (left ventricular ejection fraction 21 ± 4.1%) were evaluated. Portal vein flow was sampled from the main portal vein using intercostal approach. Systolic and diastolic flow velocities were measured and index of pulsatility (IP, max-min/max PV flow velocity) was calculated. Based on IP patients were assigned to four groups. G1-pts. with continuous or subcontinuous flow in PV, IP < 0.5, n = 12. G2-pts. with pulsatile flow, IP ≥ 5-0.99, n = 30; G3-pts. with intermittent flow, IP = 1, n = 19; G4-pts. with reverse flow during systole, IP > 1, n = 13. Investigation of central hemodynamics using termodilution catheter was done up to 48 hours after echostudies.

Results:
Median of IP in all pts. was 0.85 (0-2). IP ≥ 0.5 were found in 85 % of pts. There was a significant linear correlation of IP and right atrial pressure, pulmonary vascular resistance, and mean pulmonary artery pressure (p < 0.01, r = 0.65, 0.52 and 0.45 resp.). Pts. with severe tricuspid regurgitation (TR) (n = 29) had significantly higher IP in comparison with pts. without TR or TR of lower degrees (1.1 ± 0.38 vs. 0.69 ± 0.39, p < 0.01). Serum total bilirubin levels were lower in G1 than in the rest of the pts. (10.4 ± 4.4 vs. 25.2 ± 12.4 μmol/l, p < 0.01). We noted a decrease of body mass index (BMI) associated with increase of flow pulsatility. There was a significant difference of BMI comparing G1 with G3 of G4 (27.5 ± 4.3 vs. 22.2 ± 3.2 or 21 ± 2.7).

Conclusion:
In patients with advanced CHF the flow in PV becomes pulsatile. Pulsatility correlates with parameters of central haemodynamics, biochemical signs of congestive liver lesion and nutritional status in patients with advanced CHF.

Keywords: congestive heart failure; portal vein flow; liver lesion

Received: August 31, 2004; Accepted: October 11, 2004; Published: May 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Goncalvesová E, Lesný P, Chňupa P, Luknár M, Fabián J. Portal vein flow is associated to central hemodynamics and biochemical signs of liver lesion in chronic congestive heart failure. Vnitr Lek. 2005;51(5):533-538.
Download citation

References

  1. Batin P, Wickens M, McEntegart D et al. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Europ Heart J 1995; 16: 613-618. Go to original source... Go to PubMed...
  2. Kirsch M, Baufreton Ch, Naftel DC et al. Pretransplantation risk factors for death after heart transplantation: The Henri Mondor Experience. Journal Heart Lung Transplant 1998; 17: 268-277.
  3. Reinhartz O, Farrar DJ, Hershon JH et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 1998; 116: 633-640. Go to original source... Go to PubMed...
  4. Szántová M. Hepatálne poškodenie u kardiálneho pacienta. Medicínsky Monitor 2002; 5: 13-14.
  5. Goncalvesová E. Portálny systém. In: Kováč A et al. Abdominálna ultrasonografia. 2. ed. Martin: Osveta 1995: 323-332.
  6. Feigenbaum H. Echocardiography. 5th ed. Philadelphia: Lea & Febiger 1994.
  7. Hosoki T, Ariasawa J, Marukawa T et al. Portal blood flow in congestive heart failure: pulsed duplex sonographic findings. Radiology 1990; 174: 733-736. Go to original source... Go to PubMed...
  8. Abu-Yousef MM. Normal and respiratory variations of the hepatic and portal venous duplex doppler waveforms with simultaneous electrocardiographic correlation J Ultrasound Med 1992; 11: 263-268. Go to original source... Go to PubMed...
  9. Rengo C, Brevetti G, Sorrentino G et al. Portal vein pulsatility ratio provides a measure of right heart function in chronic heart failure. Ultrasound Med Biol 1998; 3: 327-332. Go to original source... Go to PubMed...
  10. Hu JT, Yang SS, Lai YCh et al. Percentage of peak-to-peak pulsality of portal blood flow can predict right-sided congestive. World J Gastroenterol 2003; 9: 1828-1831. Go to original source... Go to PubMed...
  11. Gallix BP, Taourel P, Dauzat M et al. Flow Pulsatility in the Portal Venous System: A Study of Doppler Sonography in Healthy Adults. AJR 1997; 69: 141-144. Go to original source... Go to PubMed...
  12. Loperfido F, Lombardo A, Amico CM et al. Doppler Analysis of Portal Vein Flow in Tricuspid Regurgitation. J Heart Valve Dis 1993; 2: 174-182. Go to PubMed...
  13. Naschitz JE, Slobodin G, Lewis RJ et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000; 140: 111-120. Go to original source... Go to PubMed...
  14. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002; 85: 51-66. Go to original source... Go to PubMed...
  15. Conraads VM, Jorens PG, De Clerck LS et al. Selective intestinal decontamination in advanced chronic heart failure: a pilot trial. Eur J Heart Fail 2004; 6: 483-491. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.